Final Flashcards
Get a 78 or higher (93 cards)
Benefits and costs are the product of:
dX: The real impact of the policy
How much does the quantity of goods (or “bads”) change as the result of the policy?
P: The valuation (price) of the impacted goods
For each good, how much value do we place on each unit gained/lost?
A market price may provide the marginal social benefit and marginal social cost of a good
Simplest case: the policy changes the quantity of a good that is currently consumed in an undistorted (i.e., efficient) market
MSB = P = MSC
Are there distortions in the market?
Taxes or subsidies result in two prices (one paid by consumers, one received by producers); which to use?
Prices in (unregulated) monopolized markets overstate the true costs (monopolists charge P > MC)
Negative externality: e.g., the “price” of pollution (in the absence of regulation) is equal to 0, but the marginal social cost is not
Positive externality: price captures marginal private benefit but understates marginal social benefit
Are “accounting” and “economic” measures the same?
E.g., data gathered from a non-profit could understate the true (opportunity) cost of volunteer’s time
If distortions exist, you need a measure of the “shadow price” (different from the market price)
Shadow price: what the market price would be if the good was traded in a market in which
demand = marginal social benefit, and
supply = marginal social cost
Two general methods for obtaining shadow prices
- Indirect market methods (BGVW Ch. 14)
- Contingent valuation methods (BGVW Ch. 15)
Indirect market methods
E.g., trade-off method, hedonic pricing, travel cost methods
Rely on “revealed” (as opposed to stated) preferences
Contingent valuation methods
Obtain values from surveys (stated preferences)
Recommend to avoid if possible
Meta-analysis
Meta-analysis is every bit as useful for determining the proper valuation of policy impacts as it is for determining the likely impacts themselves
Value of life
We previously addressed policies that affect life/death/health in cost-effectiveness section ($ per life saved)
When is CEA useful?
Fixed budget.
Fixed goal.
Ranking of alternatives.
But CEA doesn’t tell you whether the life-saving is a “good idea” per say.
Better to implement a policy that costs $1 million per life saved vs. $10 million per life saved.
But is $1 million option worth doing?
Value of (statistical) life
In general, policies subject to CBA or other analysis of this nature do not change the probability of a particular person’s death from 1 (certain death) to 0 (no chance of death) or vice-versa; they deal with small changes in the risk of death
Discussion of the “value of life” actually concerns the Value of a Statistical Life (VSL), which is a probabilistic measure
If we say that a policy will save 1 statistical life, this means that the risk of death for some group of people is reduced so that, on average, one person’s life will be saved
A policy that decreases the probability of death by 100% for 1 person saves one life
A policy that decreases the probability of death by 0.0001% for 1 million people saves one statistical life
How would you expect willingness to pay (or accept) to differ between saving a life vs. saving a statistical life?
A lot of anti-CBA rhetoric revolves around the immorality of monetizing life.
That word “statistical” is often missing and critics don’t know better.
What if we called it “value of a risk reduction” instead?
Rationale for estimating VSL
Estimating the “value of life” (VSL) does not make a philosophical statement about how much we feel a life is worth: we are simply evaluating what people’s behavior says about their willingness to pay (accept) for small decreases (increases) in the risk of death
-Private behavior indicates that people place finite value on changes to the risk of death, as they make decisions that increase the probability of death (e.g., drive cars, play contact sports, take risky jobs).
-It would be inconsistent to value risk changes infinitely in a public policy context
-If lives had infinite social value, then we should undertake any policy that has any chance of saving any number of lives, regardless of the cost (e.g., ban non-emergency use of cars?)
-By implication, we should not undertake any non-life-saving policies (e.g., public funding for education?) until we have exhausted all potentially life-saving policies (In practice, we’d run out of resources first
)
-If we want to be able to make decisions between policies that save lives and policies that do not, we need to assign value to expected lives saved
-Remember two of the basic foundations of economics: scarcity of resources and opportunity cost
Life-saving policies are funded by taxes or reduced expenditures on other policies, which may indirectly impact the probability of death
E.g., higher taxes ->less $ for healthy food, medical care, newer/safer cars, etc. -> increased risk of death
Suppose someone is willing to pay $5 to reduce the risk of a fatal accident from 2 in a million to 1 in a million
The decrease in risk is: ∆p = 0.000002 – 0.000001 = 0.000001 In this case the implied value of a statistical life is: VSL = WTP / ∆p = $5 / 0.000001 VSL = $5,000,000
Trade-off method:
determine the trade-off people are willing to make between the probability of death (or any other impact we’d like to value) and something else that is more easily monetized
Estimating VSL: wage premiums
This approach makes use of the additional wages that people require in order to accept jobs with a higher probability of death (“wage premium” or “compensating differential”)
If you require a wage premium of $400/year to accept a job with an additional 1 in 10,000 annual risk of death (otherwise identical to the best alternative job), then your implied VSL is $4,000,000
∆p * VSL = ∆wages
VSL = ∆wages / ∆p = $400 / 0.0001
Estimating VSL: consumption choices
How much will consumers pay for goods or services that reduce the probability of death?
E.g., smoke detectors, car airbags, medication
Studies of medical goods/services complicated by insurance
Related method: how does consumer behavior change in response to new information about risks?
E.g., new information comes out about how calcium supplements affect heart attack risk; how does behavior change?
What about discounting lives saved in the future?
Should be discounted; money spent to save lives today could be invested so that there would be more money available to save lives in the future (opportunity cost!)
Differences in economic status?
E.g., income effects yield different WTP for a given reduction in risk
Most analyses use an average WTP across population
Adjustments for age / life expectancy?
E.g., should we differentiate the benefit of a heart transplant for a 20 year old vs. a 85 year old?
Could, for example, determine the value of saving an additional year of statistical life, multiply by (discounted) number of expected life years saved
No conclusive theoretical basis for requiring constant (age-independent) value of a year of statistical life
Some empirical evidence that age is a factor in people’s preferences (e.g., would rather save a 30 year old than a 60 year old); valuation of prevented death by age commonly found to have inverted U shape
Voluntary vs. involuntary risks
Studies have found that involuntary risks should be valued at 1.2–1.6 times the value of voluntary risks